
Loading, please wait...

Loading, please wait...

Maintaining glaucoma driving safety is a major clinical challenge for ophthalmologists in India. Consequently, doctors must evaluate how moderate to severe glaucoma affects a patient's ability to navigate roads safely. Specifically, visual field loss and reduced contrast sensitivity can significantly impair hazard detection. Therefore, understanding the specific deficits associated with each stage of the disease is crucial for patient counseling. Likewise, recent research has highlighted the disparity between holding a valid license and being truly fit to drive under challenging conditions.
Furthermore, a study conducted in a tertiary care institute recently assessed 55 non-professional drivers with moderate to severe glaucoma. Specifically, the researchers utilized the Hodapp-Anderson-Parrish classification to categorize the participants. Moreover, they employed the Pelli-Robson chart and the Esterman visual field test (EVFT) for a comprehensive assessment of visual function. As a result, the data revealed that 40% of the participants had contrast sensitivity (CS) levels below 2.00 in their worse eye. Notably, seventeen of these patients had severe glaucoma, while five had moderate glaucoma. Accordingly, these findings suggest that disease severity directly correlates with a decline in critical driving metrics.
Similarly, the results indicated that patients with advanced glaucoma often experience a significantly reduced driving space. In addition, many of these individuals reported becoming increasingly dependent on others for their daily mobility. However, current international guidelines focus primarily on binocular visual fields rather than contrast sensitivity. Consequently, patients who pass standard field tests might still be at high risk due to poor contrast detection. Therefore, integrating CS testing into routine evaluations is highly recommended. In contrast, patients with better CS scores maintained significantly higher levels of independence and confidence behind the wheel.
In conclusion, the assessment of driving safety in glaucoma patients must be multifaceted. Instead of relying solely on visual acuity, clinicians should incorporate binocular field and contrast sensitivity data. Because these tests provide a more realistic view of a driver's performance, they are indispensable for risk management. Subsequently, early identification of at-fault risks can prevent catastrophic motor vehicle accidents. To sum up, prioritizing glaucoma driving safety ensures that patients remain mobile while keeping the roads safe for everyone.
Glaucoma reduces peripheral vision and contrast sensitivity. This makes it difficult for drivers to detect hazards, see pedestrians at night, or distinguish objects from their background in foggy weather.
The Esterman test is a binocular visual field assessment that measures the total functional area a person can see while looking straight ahead. It is widely used to determine if a driver meets legal vision requirements.
Disclaimer: This content is for informational and educational purposes only... Refer to the latest local and national guidelines for clinical practice.
References
Kaur N et al. Assessment of driving safety in non-professional drivers with moderate to severe glaucoma. Indian J Ophthalmol. 2026 Mar 12. doi: 10.4103/IJO.IJO_574_25. PMID: 41817568.
Wood JM, Black AA, Mallon K, Thomas R, Owsley C. Glaucoma and Driving: On-Road Driving Characteristics. PLoS ONE. 2016;11(7):e0158318. doi:10.1371/journal.pone.0158318.
Tatham AJ, Boer ER, Gracitelli CP, Rosen PN, Medeiros FA. Relationship Between Motor Vehicle Collisions and Results of Perimetry, Useful Field of View, and Driving Simulation in Drivers With Glaucoma. Transl Vis Sci Technol. 2015;4(6):1. doi:10.1167/tvst.4.6.1.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


New study examines driving safety in patients with moderate to severe glaucoma, highlighting the impact of contrast sensitivity on mobility and independence...
7 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today